Fidelity Investments’s Journey Medical DERM Stock Holding History
Bought
Maintained
Sold
Other funds holding DERM
Fidelity Investments's DERM Position: Q3 2026 in Review
Fidelity Investments reduced its Journey Medical (DERM) stake by 21% in Q3 2026, selling an estimated $697 and leaving 376 shares worth $2.57K. The position accounts for ﹤0.01% of the portfolio, ranked #5185.
Fidelity Investments first reported a position in DERM in Q4 2023 and has held it in 7 quarters since. The position peaked at $10.3K in Q1 2026. 74 funds tracked by Wall St. Rank hold DERM as of Q3 2026.
- Fidelity Investments held 376 shares of Journey Medical worth $2.57K as of Q3 2026.
- Fidelity Investments sold 100 Journey Medical shares in Q3 2026, an estimated $697.
- Journey Medical made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #5185 holding.
- Fidelity Investments first reported a position in Journey Medical in Q4 2023 and has held it in 7 quarters since.
- Fidelity Investments's Journey Medical position peaked at $10.3K in Q1 2026.
- 74 funds tracked by Wall St. Rank held Journey Medical as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.